Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

Delayed Quote. Delayed  - 09/26 07:05:46 pm
15.52 USD   -1.27%
02:02p IRONWOOD PHARMA : Closes $150 Million Debt Refinancing
09/07 IRONWOOD PHARMA : to Present at Morgan Stanley Global Healthcare Con..
09/01 IRONWOOD PHARMA : to Present at Wells Fargo 2016 Healthcare Conferen..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Discover our TOP LISTS, the world's most profitable stocks to hold Get it NOW!
Most relevant news about IRONWOOD PHARMACEUTICALS,
02:02p IRONWOOD PHARMACEUTICALS : Closes $150 Million Debt Refinancing
09/07 IRONWOOD PHARMACEUTICALS : to Present at Morgan Stanley Global Healthcare Confer..
09/01 IRONWOOD PHARMACEUTICALS : to Present at Wells Fargo 2016 Healthcare Conference
08/05 IRONWOOD PHARMACEUTICALS : reports 2Q loss
08/04 IRONWOOD PHARMACEUTICALS : Provides Second Quarter 2016 Investor Update
08/01IRONWOOD PHARMACEUTICALS, INC. : half-yearly earnings release
07/21 IRONWOOD PHARMACEUTICALS : to Host Second Quarter 2016 Investor Update Call
07/15 Herbalife and Ironwood advance; Infosys and Fairmount drop
06/09 IRONWOOD PHARMACEUTICALS : and Allergan Announce Supplemental New Drug Applicati..
06/06 IRONWOOD PHARMACEUTICALS : to Present at Jefferies 2016 Healthcare Conference
06/03DJASTRAZENECA : Completes US Licensing Pact with Ironwood Pharmaceuticals
06/03 IRONWOOD PHARMACEUTICALS : Closes U.S. Transaction with AstraZeneca for Lesinura..
06/01 IRONWOOD PHARMACEUTICALS : to Present at Goldman Sachs 37th Annual Global Health..
05/18 IRONWOOD PHARMACEUTICALS : to Present at 2016 UBS Global Healthcare Conference
05/17 IRONWOOD PHARMACEUTICALS : to Present Linaclotide Data at Digestive Disease Week..
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
02:15p IRONWOOD PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Creat..
02:02p IRONWOOD PHARMACEUTICALS : Closes $150 Million Debt Refinancing
09/15 IRONWOOD PHARMACEUTICALS : to Present at Morgan Stanley Global Healthcare Confer..
09/09 IRONWOOD PHARMACEUTICALS : to Present at Wells Fargo 2016 Healthcare Conference
09/07 IRONWOOD PHARMACEUTICALS : to Present at Morgan Stanley Global Healthcare Confer..
09/01 IRONWOOD PHARMACEUTICALS : to Present at Wells Fargo 2016 Healthcare Conference
08/11 IRONWOOD PHARMACEUTICALS : Patent Application Titled "Treatments for Disorders U..
08/08 IRONWOOD PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
08/05 IRONWOOD PHARMACEUTICALS : reports 2Q loss
08/04 IRONWOOD PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fi..
More news
Sector news : Biotechnology & Medical Research - NEC
04:45pDJPfizer Throws Out Plan to Split Into Two Companies
07:49aDJSANOFI : FDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for Priority Rev..
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/21DJGILEAD SCIENCES : Halts Test of Bowel Disease Treatment
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
09/22 BIONOMICS : No Longer Depressed, Opportunity Knocks
09/02 BIOMERICA : The Next Major IBS Product
08/04 Ironwood Pharmaceuticals (IRWD) Q2 2016 Results - Earnings Call Transcript
08/04 Ironwood Pharmaceuticals misses by $0.01, misses on revenue
08/03 Notable earnings after Thursday?s close
07/28 SYNERGY PHARMACEUTICALS : Attractive Acquisition Target


Advertisement
Financials ($)
Sales 2016 251 M
EBIT 2016 -78,1 M
Net income 2016 -106 M
Debt 2016 162 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 9,75x
EV / Sales 2017 7,13x
Capitalization 2 284 M
More Financials
Chart IRONWOOD PHARMACEUTICALS,
Duration : Period :
Ironwood Pharmaceuticals, Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Full-screen chart
Technical analysis trends IRONWOOD PHARMACE...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 14,8 $
Spread / Average Target -5,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Peter M. Hecht Chief Executive Officer & Director
Terrance G. McGuire Chairman
Thomas Graney Chief Financial Officer & SVP-Corporate Strategy
Mark G. Currie Chief Scientific Officer & Senior Vice President
Brian M. Cali Senior VP-Preclinical, Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
IRONWOOD PHARMACEUTICA..35.63%2 284
INCYTE CORPORATION-17.95%16 728
CELLTRION, INC.--.--%11 664
LONZA GROUP AG13.18%10 059
QUINTILES TRANSNATIONA..15.66%9 453
SEATTLE GENETICS, INC.24.40%7 845
More Results
4-traders.com :
About :
Stay Connected :
Partners :
Copyright © 2016 Surperformance. All rights reserved.